Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

BUY
$42.05 - $47.77 $44,152 - $50,158
1,050 Added 7.01%
16,038 $703,000
Q1 2022

Apr 12, 2022

BUY
$40.23 - $47.74 $266,201 - $315,895
6,617 Added 79.05%
14,988 $662,000
Q4 2021

Jan 18, 2022

BUY
$38.88 - $45.31 $325,464 - $379,290
8,371 New
8,371 $374,000
Q3 2021

Oct 07, 2021

SELL
$38.79 - $43.16 $220,559 - $245,407
-5,686 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$36.52 - $41.46 $207,652 - $235,741
5,686 New
5,686 $229,000
Q4 2020

Jan 29, 2021

SELL
$34.07 - $39.94 $295,250 - $346,120
-8,666 Closed
0 $0
Q3 2020

Oct 29, 2020

SELL
$38.11 - $42.99 $697,031 - $786,287
-18,290 Reduced 67.85%
8,666 $339,000
Q2 2020

Aug 05, 2020

BUY
$37.87 - $43.58 $290,614 - $334,432
7,674 Added 39.8%
26,956 $1.11 Million
Q1 2020

Apr 28, 2020

BUY
$32.47 - $48.83 $391,328 - $588,499
12,052 Added 166.69%
19,282 $735,000
Q4 2019

Feb 04, 2020

BUY
$42.0 - $48.25 $57,750 - $66,343
1,375 Added 23.48%
7,230 $343,000
Q3 2019

Oct 31, 2019

BUY
$40.46 - $43.52 $8,739 - $9,400
216 Added 3.83%
5,855 $253,000
Q2 2019

Jul 23, 2019

SELL
$39.4 - $42.7 $34,396 - $37,277
-873 Reduced 13.41%
5,639 $229,000
Q1 2019

Apr 12, 2019

SELL
$38.57 - $42.69 $48,906 - $54,130
-1,268 Reduced 16.3%
6,512 $280,000
Q4 2018

Jan 29, 2019

BUY
$37.8 - $42.69 $37,119 - $41,921
982 Added 14.45%
7,780 $301,000
Q3 2018

Oct 17, 2018

BUY
$39.75 - $42.69 $21,226 - $22,796
534 Added 8.52%
6,798 $276,000
Q2 2018

Jul 23, 2018

BUY
$39.61 - $42.76 $33,193 - $35,832
838 Added 15.44%
6,264 $256,000
Q1 2018

Apr 23, 2018

BUY
$36.18 - $40.15 $196,312 - $217,853
5,426 New
5,426 $216,000
Q4 2017

Jan 17, 2018

SELL
$35.34 - $41.9 $748,889 - $887,902
-21,191 Closed
0 $0
Q3 2017

Oct 23, 2017

BUY
$39.44 - $41.55 $835,773 - $880,486
21,191
21,191 $871,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Caprock Group, Inc. Portfolio

Follow Caprock Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.